Ettlin, R. and Dieterle, W. and Fabbro, D. and Hebeisen, P. and Beaufils, F. and Hillmann, P. and Stumm, M. and Dimitrijevic, S. and Wymann, M. and Cmiljanovic, N. and Giese, B. and Cmiljanovic, V.. (2015) Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types. Toxicology Letters, 238 (2, Supplement). S337-S338.
Full text not available from this repository.
Official URL: https://edoc.unibas.ch/62516/
Downloads: Statistics Overview
| Faculties and Departments: | 03 Faculty of Medicine > Departement Biomedizin > Division of Biochemistry and Genetics > Cancer- and Immunobiology (Wymann) |
|---|---|
| UniBasel Contributors: | Wymann, Matthias P. |
| Item Type: | Other |
| Publisher: | Elsevier |
| ISSN: | 0378-4274 |
| Note: | Publication type according to Uni Basel Research Database: Other publications |
| Identification Number: | |
| Last Modified: | 29 Oct 2020 12:56 |
| Deposited On: | 29 Oct 2020 12:56 |
Repository Staff Only: item control page